Analyst firms · Mizuho · ARQT

Mizuho ARQT price target and rating history

Arcutis Biotherapeutics Inc. (ARQT) · Health Care

Mizuho rates Arcutis Biotherapeutics Inc. (ARQT) Buy with a $8 price target, as of its latest action on Jan 3, 2024. It has published 3 rating actions on ARQT since June 2021, including 1 upgrade and 1 downgrade.

Current rating
Buy
Price target
$8
Median target, all firms
Too few
Actions on ARQT
3

Mizuho price target on ARQT

$58$31$420222023202420252026
Mizuho price target on ARQT, each point a stated target, June 2021 to January 2024.

Every Mizuho rating on ARQT

Questions about Mizuho and ARQT

What is Mizuho's price target for ARQT?
Mizuho's latest stated price target for Arcutis Biotherapeutics Inc. (ARQT) is $8, from its action on Jan 3, 2024.
What is Mizuho's rating on ARQT?
Mizuho rates ARQT Buy, a bullish rating, as of Jan 3, 2024.
When did Mizuho last change its view on ARQT?
On Jan 3, 2024, Mizuho upgrades to Buy from Neutral, price target $4 to $8.

More ARQT rating histories

All Mizuho ratingsARQT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.